Small airway remodeling in idiopathic interstitial pneumonias: A pathological study

Respiration

Volumn 79, Issue 4, 2010, Pages 322-332

  Figueira De Mello, George Castro ^a   Ribeiro Carvalho, Carlos Roberto ^a   Adib Kairalla, Ronaldo ^a   Nascimento Saldiva, Paulo Hilário ^a   Fernezlian, Sandra ^a   Ferraz Silva, Luiz Fernando ^a   Dolhnikoff, Marisa ^a   Mauad, Thais ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Interstitial lung disease; Matrix metalloproteinase; Pneumonia, nonspecific interstitial; Small airways

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; AIRWAY; ARTICLE; AUTOPSY; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRONCHIOLES; FEMALE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 77949263632     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235722     Document Type: Article

References (45)

1. Chung MP, Rhee CH: Airway obstruction in interstitial lung disease. Curr Opin Pulm Med 1997;3:332-335.
2. American Thoracic Society, European Respiratory Society: International multidisci-plinary consensus classification of the idiopathic interstitial pneumonias. Am Respir Crit Care Med 2002;165:277-304.
3. Chetta A, Marangio E, Olivieri D: Pulmonary function testing in interstitial lung diseases. Respiration 2004;71:209-213.
4. Ostrow D, Cherniack RM: Resistance to airflow in patients with diffuse interstitial lung disease. Am Rev Respir Dis 1973;108:205-210.
5. Fulmer JD, Roberts WC, Von Gal ER, Crystal RG: Small airways in idiopathic pulmonary fibrosis - comparison of morphologic and physiologic observations. J Clin Invest 1977;60:595-610.
6. Schofield NM, Davies RJ, Cameron IR, Green M: Small airways in fibrosing alveolitis. Am Rev Respir Dis 1976;113:729-735.
7. Holgate ST, Lackie P, Wilson S, Roche W, Davies D: Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med 2000;162:S113-S179.
8. Gueders MM, Foidart JM, Noel A, Cataldo DD: Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006;533:133-144.
9. Holgate ST: Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007;12:1233-1244.
10. Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, Ando M: Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000;162:1949-1956.
11. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N: Localization of matrix metal-loproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998;78:687-698.
12. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A: TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microen-vironment? Am J Physiol Lung Cell Mol Physiol 2000;279:562-574.
13. Cosgrove GP, Schwarz MI, Geraci MW, Brown KK, Worthen GS: Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis. Chest 2002;121:25S-26S.
14. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, Aziz N, Kaminski N, Zlotnik A: Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-198.
15. Odajima N, Betsuyaku T, Nasuhara Y, Itoh T, Fukuda Y, Senior RM, Nishimura M: Extracellular matrix metalloproteinase inducer in interstitial pneumonias. Hum Pathol 2006;37:1058-1065.
16. Sheppard D: Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006;3:413-417.
17. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH: Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991;5:155-162.
18. Visscher DW, Myers JL: Bronchiolitis: the pathologist's perspective. Proc Am Thorac Soc 2006;3:41-47.
19. Visscher DW, Myers JL: Histologic spectrum of idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3:322-329.
20. Mauad T, Xavier ACG, Saldiva PHN, Dolh-nikoff M: Elastosis and fragmentation of fibers of the elastic system in fatal asthma. Am J Respir Crit Care Med 1999;160:968-975.
21. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
22. Bai A, Eidelman DH, Hogg JC, James AL, Lambert RK, Ludwig MS, Martin J, McDonald DM, Mitzner WA, Okazawa M, Pack RJ, Pare PD, Schellenberg RR, Tiddens HAWM, Wagner EM, Yager D: Proposed nomenclature for quantifying subdivisions of the bronchial wall. J Appl Physiol 1994;7:1011-1014.
23. De Boer WI, Hiemstra PS, Sont JK, De Heer E, Rabe KF, Van Krieken JHJM, Sterk PJ: Image analysis and quantification in lung tissue. Clin Exp Allergy 2001;31:504-508.
24. Sont JK, De Boer WI, Van Schadewijk WAAM, Grunberg K, Van Krieken JHJM, Hiemstra PS, Sterk PJ; Asthma Management Project University of Leiden Study Group: Fully automated assessment of inflammatory cell counts and cytokine expression in bronchial tissue. Am J Respir Crit Care Med 2003;167:1496-1503.
25. Cordier JF: Challenges in pulmonary fibrosis 2: bronchiolocentric fibrosis. Thorax 2007;62:638-649.
26. Weibel ER: Design of airways and blood vessels considered as branching trees; in Barnes PJ, Weibel ER, West JB, Crystal RG (eds): The Lung - Scientific Foundations, ed 2. Philadelphia, Lippincott-Raven, 1997, pp 1061-1071.
27. Padilla RP, Gaxiola M, Salas J, Mejia M, Ramos C, Selman M: Bronchiolitis in chronic pigeon breeder's disease - morphologic evidence of a spectrum of small airway lesions in hypersensitivity pneumonitis induced by avian antigens. Chest 1996;110:371-377.
28. Myre M, Allard S, Bernard C, Martin RR: Clinical, functional and pathological correspondence in early stage idiopathic pulmonary fibrosis: evidence for small airway obstruction 1-2. Respiration 1988;53:174-186.
29. Flaherty KR, Martinez FJ: Nonspecific interstitial pneumonia. Semin Respir Crit Care Med 2006;27:652-658.
30. Wilcox AG: Small airway involvement in interstitial lung disease: radiologic evidence. Curr Opin Pulm Med 2000;6:399-403.
31. Wu Z, Yang L, Cai L, Zhang M, Cheng X, Yang X, Xu J: Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an α-smooth muscle actin-Cre transgenic mouse. Respir Res 2007;8:1.
32. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, Parks WC: Matrilysin expression and function in airway epithelium. J Clin Invest 1998;102:1321-1331.
33. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, Sheppard D, Pardo A, Selman M, Heller RA: Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002;99:6292-6297.
34. Vourinen K, Myllarniemi M, Lammi L, Piirila P, Rytila P, Salmenkivi K, Kinnula V: Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases. APMIS 2007;115:969-975.
35. Parks WC, Lopez-Boado YS, Wilson CL: Matrilysin in epithelial repair and defense. Chest 2001;120:36-41.
36. Manoury B, Caulet-Maugendre S, Guénon I, Lagente V, Boichot E: TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol 2006;19:471-487.
37. Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, Fenoglio C, Perlini S, Pozzi E: Time course of matrix metallo-proteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis. Eur J Histochem 2006;50:317-325.
38. Calabresi C, Arosio B, Galimberti L, Scanziani E, Bergottini R, Annoni G, Vergani C: Natural aging, expression of fibrosis-related genes and collagen deposition in rat lung. Exp Gerontol 2007;42:1003-1011.
39. Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, Travis WD, McCoy JP, May RM, Wu HP, Nguyen DM, Arcos-Burgos M, MacDonald SD, Gochuico BR: Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:698-705.
40. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pek kanen R, Muller N, Colby TV, S chuy ler M, Cor mier Y; HP Study Group: Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952-958.
41. Erkinjuntti-Pekkanen R, Kokkarinen JI, Tukiainen HO, Pekkanen J, Husman K, Terho EO: Long-term outcome of pulmonary function in farmer's lung: a 14 year follow-up with matched controls. Eur Respir J 1997;10:2046-2050.
42. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM OP): Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26:586-593.
43. Jankowich MD, Polsky M, Klein M, Rounds S: Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008;75:411-417.
44. Tan CSH, Tashkin DP: Supernormal maximal mid-expiratory flow rates in diffuse interstitial lung disease. Respiration 1981;42:200-208.
45. Mauad T, Schadewijk AV, Schrumpf J, Hack CE, Fernezlian S, Garippo AL, Ejzenberg B, Hiemstra PS, Rabe KF, Dolhnikoff M; São Paulo BO Study Group: Lymphocytic inflammation in childhood bronchiolitis obliterans. Pediatr Pulmonol 2004;38:233-239.